← Human Trials & Peer-Reviewed Studies

[The study of growth hormone on wound healing rate in adult burns].

Plain-language guide to PMID 11501126 (1999): randomized controlled trial of Exogenous HGH, sermorelin & older GHRPs (why they're passed over) in 42 patients.

Key Facts

PMID
11501126
Journal
Zhonghua zheng xing shao shang wai ke za zhi = Zhonghua zheng xing shao shang waikf [i.e. waike] zazhi = Chinese journal of plastic surgery and burns
Year
1999
Study type
Randomized Controlled Trial
Authors
Chen H et al. (3 authors)

What This Study Did, in Plain Language

What Was Tested

Researchers studied Exogenous HGH, sermorelin & older GHRPs (why they're passed over) in this randomized controlled trial publication.

To determine the effects of rhGH on wound healing in adult burn patients.

Who Took Part

The study group was 42 patients.

By PubMed's age tags, the people studied were teenagers and adults, both men and women.

The control group patients were given normal saline as placebo.

How the Study Was Run

In design terms this was a randomized and placebo-controlled study.

Because people in this Exogenous HGH, sermorelin & older GHRPs (why they're passed over) study were split into groups at random, differences between the groups are less likely to reflect who happened to join each one.

The comparison arm used a placebo, so changes seen with Exogenous HGH, sermorelin & older GHRPs (why they're passed over) could be set against what happens without it.

They were comparable in nutrient intake, TBSA, and full thickness burn area.

Protein catabolism, immunocompetence, healing time of burn wounds and donor sites were assayed.

What Was Measured

Topics PubMed links to this paper include Burns, Growth Hormone, Proteins and Wound Healing.

What This Means in Plain Language

The paper is a randomized and placebo-controlled study of Exogenous HGH, sermorelin & older GHRPs (why they're passed over) in 42 patients.

The abstract goes on to report its results in about 3 sentences; this page does not restate them, so read the paper for the findings and their limits.

The publication is from 1999 (Zhonghua zheng xing shao shang wai ke za zhi = Zhonghua zheng xing shao shang waikf [i.e. waike] zazhi = Chinese journal of plastic surgery and burns), a journal based in China.

More context: the Exogenous HGH, sermorelin & older GHRPs (why they're passed over) compound page, all human trials.

Our Notes on the Compound

Exogenous HGH, sermorelin & older GHRPs (why they're passed over): Constant levels suppress the body's own GHRH, raise somatostatin and dull pituitary response.

Related Pages

Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.